November 04, 2026

Low PET uptake may mask aortic sarcoma

Recurrent arterial embolization prompted surgery after imaging suggested thrombus, but definitive pathology revealed malignancy.

MDSpire News

October 30, 2026

Monthly fasting cycles may be feasible in T2D

Nearly 1 in 3 participants discontinued the yearlong dietary program because of diet-related challenges, despite a 61% completion rate.

MDSpire News

October 29, 2026

Digoxin misses heart failure endpoint

Researchers observed fewer worsening heart failure events, but the trial did not establish a statistically significant benefit.

MDSpire News

October 29, 2026

FDA monthly preview: Key November decisions to watch

Upcoming FDA decisions span cancer, cardiovascular disease, rare genetic disorders, and more.

MDSpire News

October 27, 2026

4 societies redefine women's heart care

New multisociety guidance identifies menstrual irregularities as potential early markers of cardiovascular risk, extending prevention efforts into adolescence.

MDSpire News

October 26, 2026

Remote care may reduce heart failure events

Daily biometric monitoring and structured video consultations supported earlier intervention during the posthospitalizationvulnerable period.

MDSpire News

October 22, 2026

Biomaterial approach may help cartilage retain shape

Stem cell–laden constructs maintained curved architecture for 6 days after investigators removed supporting hydrogel framework.

MDSpire News

October 22, 2026

Medical Oddities: When puberty arrives at 4 months old

A genetic mystery, hearts in space, midnight munchies, and tea with muscle power are in the lineup this week.

MDSpire News

October 16, 2026

Frailty may not limit semaglutide benefits

Patients with greater frailty showed larger improvements in health-related quality of life, while cardiovascular treatment effects did not differ significantly across frailty categories.

MDSpire News

October 15, 2026

Anticoagulant recalled over life-threatening risk

Contamination in 22 lots of the injection may cause pulmonary embolism or vascular occlusion; no related adverse events reported.

MDSpire News